scholarly article | Q13442814 |
P50 | author | Ming-Sound Tsao | Q47492209 |
P2093 | author name string | S Yi | |
P2860 | cites work | Molecular cloning and expression of human hepatocyte growth factor | Q24305558 |
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 | ||
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor | Q24555664 | ||
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase | Q28286701 | ||
Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
Improved retroviral vectors for gene transfer and expression | Q29614384 | ||
Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing | Q33263389 | ||
Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement | Q34294357 | ||
Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation | Q35277738 | ||
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor | Q35961109 | ||
Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts | Q35975907 | ||
Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. | Q36136355 | ||
Scatter factor induces blood vessel formation in vivo | Q36141804 | ||
Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells | Q36223889 | ||
Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells | Q36236279 | ||
Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines | Q36292961 | ||
Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network | Q36557528 | ||
NCI-Navy Medical Oncology Branch cell line data base | Q36819549 | ||
Evidence for the identity of human scatter factor and human hepatocyte growth factor | Q37574028 | ||
Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity | Q38293448 | ||
Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor | Q38324229 | ||
Packaging system for rapid production of murine leukemia virus vectors with variable tropism | Q40067097 | ||
Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction | Q40560399 | ||
Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells | Q40959364 | ||
Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes | Q40987654 | ||
Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma | Q40994798 | ||
Decreased fibronectin expression in Met/HGF-mediated tumorigenesis | Q41004407 | ||
Emerging multipotent aspects of hepatocyte growth factor | Q41066829 | ||
Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactions | Q41079250 | ||
Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis | Q41188806 | ||
Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth | Q41596252 | ||
Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor | Q41656206 | ||
Growth Factor–dependent Activation of αvβ3 Integrin in Normal Epithelial Cells: Implications for Tumor Invasion | Q42796734 | ||
Adenovirus-mediated manganese superoxide dismutase gene transfer to hamster cheek pouch carcinoma cells. | Q44115873 | ||
Up-regulation of Vascular Endothelial Growth Factor Induced by Hepatocyte Growth Factor/Scatter Factor Stimulation in Human Glioma Cells | Q47680471 | ||
Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers | Q47706538 | ||
The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review). | Q47767769 | ||
Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo | Q48744988 | ||
Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells | Q57272714 | ||
Gradation of carcinogen-induced capacity for anchorage-independent growth in cultured rat liver epithelial cells | Q57272762 | ||
Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers | Q71478326 | ||
Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity | Q72306296 | ||
Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer | Q73023180 | ||
Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas | Q73027878 | ||
Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice | Q73273511 | ||
P433 | issue | 3 | |
P921 | main subject | adenocarcinoma | Q356033 |
P304 | page(s) | 226-234 | |
P577 | publication date | 2000-05-01 | |
P1433 | published in | Neoplasia | Q2962042 |
P1476 | title | Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line | |
P478 | volume | 2 |
Q40714043 | A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line |
Q39029873 | Analysis of HGF, MACC1, C-met and apoptosis-related genes in cervical carcinoma mice |
Q54949177 | Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer. |
Q26751332 | Biomarker development in MET-targeted therapy |
Q35041171 | C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis |
Q40710285 | CD44 stimulation by fragmented hyaluronic acid induces upregulation and tyrosine phosphorylation of c-Met receptor protein in human chondrosarcoma cells |
Q35201636 | Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression |
Q30492361 | Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells |
Q40706645 | Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival |
Q90465717 | Correlation between Bax gene polymorphisms and esophagus cancer |
Q38930336 | Diagnosis and Molecular Classification of Lung Cancer |
Q91798036 | Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy |
Q44737495 | Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy |
Q40464303 | Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c. |
Q36660673 | MET As a Possible Target for Non–Small-Cell Lung Cancer |
Q37232416 | MET as a target for treatment of chest tumors |
Q89603062 | MET targeting: time for a rematch |
Q49888000 | Mechanisms of receptor tyrosine kinase activation in cancer |
Q36828371 | Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy |
Q38869428 | Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase Inhibitors |
Q26860232 | Prognostic value of c-Met in colorectal cancer: a meta-analysis |
Q24609682 | The MET axis as a therapeutic target |
Q39274990 | The c-Met receptor: Implication for targeted therapies in colorectal cancer |
Q35563524 | The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis |
Q37962905 | c-MET as a potential therapeutic target and biomarker in cancer |
Q36731520 | c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy |